CPA
ARCT icon

Cowen Prime Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Cowen Prime Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-800
Closed -$11K – 178
2020
Q1 		$11K Hold
800
– – 0.01% 148
2019
Q4 		$9K Buy
+800
New +$8.37K ﹤0.01% 151

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Cowen Prime Advisors's ARCT Position: Q2 2020 in Review

Cowen Prime Advisors sold out of Arcturus Therapeutics (ARCT) in Q2 2020, closing a stake of 800 shares — an estimated $11K sold.

Cowen Prime Advisors first reported a position in ARCT in Q4 2019 and held it in 2 quarters. The position peaked at $11K in Q1 2020. 114 funds tracked by Wall St. Rank hold ARCT as of Q2 2020.

  • Cowen Prime Advisors reported no remaining Arcturus Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Cowen Prime Advisors sold 800 Arcturus Therapeutics shares in Q2 2020, an estimated $11K.
  • Cowen Prime Advisors first reported a position in Arcturus Therapeutics in Q4 2019 and held it in 2 quarters.
  • Cowen Prime Advisors's Arcturus Therapeutics position peaked at $11K in Q1 2020.
  • 114 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2020.

Based on Cowen Prime Advisors's 13F filing for Q2 2020, filed 29 Jul 2020.